Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
Robin ArcaniDaniel BertinNathalie BardinKarin MazodierRodolphe JeanPierre SuchonGeoffroy VentonAurélie DaumasEstelle JeanPatrick VillaniGilles KaplanskiPierre-André JarrotPublished in: Rheumatology (Oxford, England) (2021)
Although rare, anti-NuMA antibodies are mainly associated with pSS and SLE and may be useful for diagnosis when other auto-antibodies are negative. PSS and SLE patients with anti-NuMA antibodies have less severe clinical and biological profiles, suggesting that anti-NuMA antibodies may constitute a good prognosis marker in both autoimmune diseases.